Neuralink develops implantable brain-computer interfaces designed to translate neural signals into digital commands. The company's work sits at the intersection of neuroscience, microscale electronics, and biomedical engineering, operating within the neurotechnology and medical devices sectors.
The company's primary product, the N1 implant, is a fully implantable and cosmetically invisible device. It is intended to enable individuals with quadriplegia to control computers and mobile devices using their thoughts. Neuralink has received FDA approval for human clinical trials, and patients are already using the devices to control computers.
